Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 96 (10) , 1128-1137
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential TargetsThe American Journal of Pathology, 2013
- Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genesGenes, Chromosomes and Cancer, 2012
- Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression dataGenes, Chromosomes and Cancer, 2011
- Unleashing the power of inhibitors of oncogenic kinases through BH3 mimeticsNature Reviews Cancer, 2009
- Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adultsCancer, 2008
- ETV6-NCOA2: A Novel Fusion Gene in Acute Leukemia Associated with Coexpression of T-Lymphoid and Myeloid Markers and Frequent NOTCH1 MutationsClinical Cancer Research, 2008
- Multidrug resistance‐1 and p‐glycoprotein in human chondrosarcoma cell lines: Expression correlates with decreased intracellular doxorubicin and in vitro chemoresistanceJournal of Orthopaedic Research, 1999
- Chemotherapy and P‐glycoprotein expression in chondrosarcomaJournal of Orthopaedic Research, 1998
- Combined metaphase, interphase cytogenetic, and flow cytometric analysis of DNA content of pediatric acute lymphoblastic leukemiaCytometry, 1998
- Mesenchymal ChondrosarcomaClinical Orthopaedics and Related Research, 1981